The latest closing stock price for Virpax Pharmaceuticals as of September 18, 2024 is 0.76.
An investor who bought $1,000 worth of Virpax Pharmaceuticals stock at the IPO in 2021 would have $-884 today, roughly -1 times their original investment - a -41.67% compound annual growth rate over 4 years.
The all-time high Virpax Pharmaceuticals stock closing price was 22.90 on August 18, 2021.
The Virpax Pharmaceuticals 52-week high stock price is 5.48, which is 621.1% above the current share price.
The Virpax Pharmaceuticals 52-week low stock price is 0.24, which is 68.4% below the current share price.
The average Virpax Pharmaceuticals stock price for the last 52 weeks is 1.28.
An investor who bought $1,000 worth of Virpax Pharmaceuticals stock at the IPO in 2021 would have $-884 today, roughly -1 times their original investment - a -41.67% compound annual growth rate over 4 years.
The all-time high Virpax Pharmaceuticals stock closing price was 22.90 on August 18, 2021.
The Virpax Pharmaceuticals 52-week high stock price is 5.48, which is 621.1% above the current share price.
The Virpax Pharmaceuticals 52-week low stock price is 0.24, which is 68.4% below the current share price.
The average Virpax Pharmaceuticals stock price for the last 52 weeks is 1.28.